Integra LifeSciences Holdings Corporation
corporate_fare Company Profile
Integra LifeSciences Holdings Corporation (NASDAQ:IART) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for IART at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-21, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for IART spans 8-K, 10-Q, DEF 14A.
Recent high-impact activity:
- Integra Life Slides to May Lows as Tissue Reconstruction Drags Q3 Revenue Below Consensus
- Integra Q3 EPS Beat; 2026 Guidance Reaffirmed After $2.1B Refinancing
- Integra Posts $14.9M Third-Quarter Net Income
- Integra Closes $450M 9.500% Notes and $1.65B Refinanced Credit Facility
- Integra Prices $450M Senior Secured Notes at 9.5% in Refinancing
Financial Snapshot
Short Interest & Short Volume
6.37 days to coverFINRA reported short interest of 7,895,702 shares in IART as of the October 30, 2026 settlement, a 7.9% increase from the prior period — about 6.4 days to cover at its recent average daily volume. On November 20, 2026, 79.2% of IART volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.